InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Leung Gabriel, Director. Director active across 1 company, notably NovoCure Ltd. Aggregated, 10 filings have been published. Split: 0 buy · 2 sells. Total volume traded: €36k. History available since 5 May 2021. The latest transaction was disclosed on 4 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Leung Gabriel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
11,215 股0Ordinary SharesSEC:0001562180-25-004562:0
999 股@ US$17.314610.7% 占其流量Ordinary SharesSEC:0001562180-25-004440:0
964 股@ US$23.885110.3% 占其流量Ordinary SharesSEC:0001562180-24-004758:0
3,853 股0Restricted Stock UnitsSEC:0001562180-23-005013:0
2,427 股0Restricted Stock UnitsSEC:0001645113-22-000051:0
1,000 股@ US$31.4518.8% 占其流量Ordinary SharesSEC:0001645113-21-000099:0
1,000 股@ US$31.4518.8% 占其流量Ordinary SharesSEC:0001645113-21-000081:0
814 股0Restricted Stock UnitsSEC:0001645113-21-000074:0
1,000 股@ US$31.4518.2% 占其流量Ordinary SharesSEC:0001645113-21-000070:0
1,000 股@ US$31.4518.5% 占其流量Ordinary SharesSEC:0001645113-21-000064:0
10 条申报中的 10 条
About Leung Gabriel
Gabriel Leung is a director at NovoCure Ltd. In this role, he is responsible for overseeing the company's operations and implementing strategies to achieve financial objectives. His management expertise is essential for ensuring the growth and profitability of NovoCure.
